×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Bionano Genomics Inc. (BNGO) NASDAQ

$0.78 (0.04) (-4.38%)

Market Cap: $44.62M

As of 04/18/24 03:43 PM EDT. Market closed.

(BNGO)

Bionano Genomics Inc. (BNGO)
NASDAQ

$0.78
(0.04) (-4.38%)

Market Cap: $44.62M

As of 04/18/24 03:43 PM EDT. Market closed.

Add to Portfolio

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can ... read more

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Testing Laboratories
CEO
R. Erik Holmlin
Full Time Employees
313
URL
Address
9540 Towne Centre Dr Ste 100, California, San Diego, 92121-1989.
Sector
Professional, Scientific, and Technical Services
Industry
Testing Laboratories
CEO
R. Erik Holmlin
Full Time Employees
313
Address
9540 Towne Centre Dr Ste 100, California, San Diego, 92121-1989.
PRICE CHART FOR BIONANO GENOMICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.79
Previous Close
$0.82
Days Range
$0.79 - $0.89
52 week range
$0.79 - $8.20
Volume
2,361,429
Avg. Volume (30 days)
1,730,108
Market Cap
$44.62M
Dividend Yield
-
P/E
(0.19)
Shares Outstanding
54,694,000
Open
$0.79
Previous Close
$0.82
Days Range
$0.79 - $0.89
52 week range
$0.79 - $8.20
Volume
2,361,429
Avg. Volume (30 days)
1,730,108
Market Cap
$44.62M
Dividend Yield
-
P/E
(0.19)
Shares Outstanding
54,694,000
FINANCIAL STATEMENTS FOR BIONANO GENOMICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIONANO GENOMICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Chaubey AlkaCHIEF MEDICAL OFFICERFeb 15, 2024 Option Exercise$1.271,0811,37331,487Mar 05, 2024, 05:48 PM
OLDAKOWSKI MARKCHIEF OPERATING OFFICERFeb 15, 2024 Option Exercise$1.271,2291,56148,644Mar 05, 2024, 05:47 PM
Holmlin R. ErikPRESIDENT AND CEOFeb 15, 2024 Option Exercise$1.273,0733,90377,663Mar 05, 2024, 05:46 PM
Dixon Jonathan V.GENERAL COUNSELFeb 15, 2024 Option Exercise$1.274025113,525Mar 05, 2024, 05:44 PM
Mamuszka HannahDirectorJun 13, 2023 Buy$0.7665,78950,00065,789Jun 14, 2023, 06:32 PM
Holmlin R. ErikPresident and CEOMay 16, 2023 Buy$0.6415,0009,639806,474May 16, 2023, 06:23 PM
Stewart Christopher P.Chief Financial OfficerMay 12, 2023 Buy$0.6750,00033,415281,373May 16, 2023, 06:22 PM
OLDAKOWSKI MARKChief Operating OfficerMay 12, 2023 Option Exercise$0.6641,49627,387297,842May 16, 2023, 06:20 PM
Holmlin R. ErikPresident and CEOMay 12, 2023 Option Exercise$0.6650,14133,093791,474May 16, 2023, 06:18 PM
Linney YvonneDirectorAug 15, 2022 Option Exercise$0.3820,0007,60020,000Aug 17, 2022, 05:55 PM
Linney YvonneDirectorAug 15, 2022 Sale$3.6220,00072,4020Aug 17, 2022, 05:55 PM
BARKER DAVID LDirectorJul 07, 2022 Option Exercise$0.5144,47022,68058,364Jul 11, 2022, 04:51 PM
BARKER DAVID LDirectorMay 16, 2022 Buy$1.6010,00016,00013,894May 18, 2022, 04:16 PM
Stewart Christopher P.Chief Financial OfficerMay 13, 2022 Option Exercise$0.5660,00033,600121,579May 16, 2022, 09:31 PM
OLDAKOWSKI MARKChief Operating OfficerMay 12, 2022 Option Exercise$1.4141,49658,509216,669May 16, 2022, 09:27 PM
Holmlin R. ErikPresident and CEOMay 12, 2022 Option Exercise$1.4150,14170,699538,556May 16, 2022, 09:23 PM
Holmlin R. ErikPresident and CEONov 29, 2021 Buy$3.995,02520,0375,025Dec 01, 2021, 06:00 AM
Stewart Christopher P.Chief Financial OfficerNov 19, 2021 Option Exercise$0.5622,50012,60055,500Nov 23, 2021, 06:00 AM
Stewart Christopher P.Chief Financial OfficerJan 22, 2021 Option Exercise$6.008,00048,0008,000Jan 25, 2021, 04:24 PM
TWOMEY CHRISTOPHER JDirectorApr 06, 2020 Option Exercise$0.3245,00014,40064,500Apr 07, 2020, 02:50 PM
TWOMEY CHRISTOPHER JDirectorOct 23, 2019 Option Exercise$0.859,5008,07519,500Oct 25, 2019, 03:15 PM
Borodkin MarkChief Operating OfficerJan 18, 2019 Option Exercise$1.306,0007,8006,815Jan 22, 2019, 09:08 PM
BARKER DAVID LDirectorAug 21, 2018 Buy$6.473,89425,1943,894Oct 03, 2018, 04:42 PM
Holmlin R. ErikPresident and CEOAug 23, 2018 Buy$6.131,6309,9841,630Aug 27, 2018, 06:53 PM
Borodkin MarkChief Operating OfficerAug 23, 2018 Buy$6.138154,992815Aug 27, 2018, 06:52 PM
TWOMEY CHRISTOPHER JDirectorAug 23, 2018 Buy$6.1310,00061,25010,000Aug 27, 2018, 06:47 PM
DP VIII Associates, L.P.10% OwnerAug 23, 2018 Option Exercise$4.592,50511,4986,891Aug 27, 2018, 05:20 PM
Domain Partners VIII, L.P.10% OwnerAug 23, 2018 Option Exercise$4.59337,6941,550,016929,878Aug 27, 2018, 05:03 PM
Domain Partners VIII, L.P.10% OwnerAug 23, 2018 Buy$6.1315,00091,875943,878Aug 27, 2018, 05:03 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Chaubey AlkaCHIEF MEDICAL OFFICER02/15/20241,373
OLDAKOWSKI MARKCHIEF OPERATING OFFICER02/15/20241,561
Holmlin R. ErikPRESIDENT AND CEO02/15/20243,903
Dixon Jonathan V.GENERAL COUNSEL02/15/2024511
Mamuszka HannahDirector06/13/202350,000
Holmlin R. ErikPresident and CEO05/16/20239,639
Stewart Christopher P.Chief Financial Officer05/12/202333,415
OLDAKOWSKI MARKChief Operating Officer05/12/202327,387
Holmlin R. ErikPresident and CEO05/12/202333,093
Linney YvonneDirector08/15/20227,600
Linney YvonneDirector08/15/202272,402
BARKER DAVID LDirector07/07/202222,680
BARKER DAVID LDirector05/16/202216,000
Stewart Christopher P.Chief Financial Officer05/13/202233,600
OLDAKOWSKI MARKChief Operating Officer05/12/202258,509
Holmlin R. ErikPresident and CEO05/12/202270,699
Holmlin R. ErikPresident and CEO11/29/202120,037
Stewart Christopher P.Chief Financial Officer11/19/202112,600
Stewart Christopher P.Chief Financial Officer01/22/202148,000
TWOMEY CHRISTOPHER JDirector04/06/202014,400
TWOMEY CHRISTOPHER JDirector10/23/20198,075
Borodkin MarkChief Operating Officer01/18/20197,800
BARKER DAVID LDirector08/21/201825,194
Holmlin R. ErikPresident and CEO08/23/20189,984
Borodkin MarkChief Operating Officer08/23/20184,992
TWOMEY CHRISTOPHER JDirector08/23/201861,250
DP VIII Associates, L.P.10% Owner08/23/201811,498
Domain Partners VIII, L.P.10% Owner08/23/20181,550,016
Domain Partners VIII, L.P.10% Owner08/23/201891,875
Load More Insider Transactions
FUNDS WITH A POSITION IN BIONANO GENOMICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC514,2300.0015%NewOther
BLACKROCK INC.505,3600.00002%-12.16%Other
GEODE CAPITAL MANAGEMENT, LLC376,8020.00007%10.17%Other
D. E. SHAW & CO., INC.171,7570.00028%NewOther
CHANGE IN SHARES OUTSTANDING FOR BIONANO GENOMICS INC
STOCK BUYBACKS FOR BIONANO GENOMICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
13.89%
1Q
12/31/2023
06/30/2023
26.55%
2Q
12/31/2023
03/31/2023
31.97%
3Q
12/31/2023
12/31/2022
34.24%
4Q
12/31/2023
09/30/2022
37.60%
5Q
12/31/2023
06/30/2022
39.60%
6Q
12/31/2023
03/31/2022
40.06%
7Q
12/31/2023
12/31/2021
40.38%
8Q
12/31/2023
09/30/2021
42.28%
9Q
12/31/2023
06/30/2021
42.93%
10Q
12/31/2023
03/31/2021
51.03%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
13.89%
1Q
06/30/2023
26.55%
2Q
03/31/2023
31.97%
3Q
12/31/2022
34.24%
4Q
09/30/2022
37.60%
5Q
06/30/2022
39.60%
6Q
03/31/2022
40.06%
7Q
12/31/2021
40.38%
8Q
09/30/2021
42.28%
9Q
06/30/2021
42.93%
10Q
03/31/2021
51.03%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIONANO GENOMICS INC
LOADING...